| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
L-648051
ID: ALA282253
Max Phase: Preclinical
Molecular Formula: C24H28O8S
Molecular Weight: 476.55
Molecule Type: Small molecule
Associated Items:
Representations
Synonyms (1): L-648051
Synonyms from Alternative Forms(1):
Canonical SMILES: CCCc1c(OCCCS(=O)(=O)c2ccc(C(=O)CCC(=O)O)cc2)ccc(C(C)=O)c1O
Standard InChI: InChI=1S/C24H28O8S/c1-3-5-20-22(12-10-19(16(2)25)24(20)29)32-14-4-15-33(30,31)18-8-6-17(7-9-18)21(26)11-13-23(27)28/h6-10,12,29H,3-5,11,13-15H2,1-2H3,(H,27,28)
Standard InChI Key: ZAKKEARLDPTRLX-UHFFFAOYSA-N
Associated Targets(Human)
Cysteinyl leukotriene receptor 1147 Activities
Homo sapiens 32628 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Cavia porcellus 23802 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 476.55 | Molecular Weight (Monoisotopic): 476.1505 | AlogP: 3.84 | #Rotatable Bonds: 13 |
| Polar Surface Area: 135.04 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.06 | CX Basic pKa: | CX LogP: 3.36 | CX LogD: -0.11 |
| Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.33 | Np Likeness Score: -0.42 |
References
| 1. Shaw A, Krell RD.. (1991) Peptide leukotrienes: current status of research., 34 (4): [PMID:1849993] [10.1021/jm00108a001] |
| 2. Cohen N, Weber G, Banner BL, Lopresti RJ, Schaer B, Focella A, Zenchoff GB, Chiu AM, Todaro L, O'Donnell M.. (1989) 3,4-Dihydro-2H-1-benzopyran-2-carboxylic acids and related compounds as leukotriene antagonists., 32 (8): [PMID:2547071] [10.1021/jm00128a028] |
| 3. Brooks CD, Summers JB.. (1996) Modulators of leukotriene biosynthesis and receptor activation., 39 (14): [PMID:8709092] [10.1021/jm960088k] |
Source
Source(1):